Brainsway News

Ladenburg Thalmann Maintains Brainsway(BWAY.US) With Buy Rating, Raises Target Price to $13.4

Moomoo NewsNov 13 09:33 ET

BrainsWay Analyst Ratings

BenzingaOct 21 06:52 ET

H.C. Wainwright Maintains Brainsway(BWAY.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsOct 21 06:31 ET

BrainsWay Analyst Ratings

BenzingaSep 16 13:20 ET

H.C. Wainwright Maintains Brainsway(BWAY.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsSep 16 10:31 ET

Brainsway's Growth Trajectory: Strong Buy Rating Justified by Expansion and Strategic Developments

TipRanksSep 16 09:39 ET

Brainsway Price Target Raised to $16.00/Share From $15.00 by HC Wainwright & Co.

Dow JonesAug 8 07:56 ET

BrainsWay Analyst Ratings

BenzingaAug 7 13:54 ET

Analysts Conflicted on These Healthcare Names: Brainsway (BWAY) and G1 Therapeutics (GTHX)

TipRanksAug 7 09:24 ET

Brainsway (BWAY) Gets a Buy From Northland Securities

TipRanksAug 7 09:24 ET

Buy Rating Affirmed for Brainsway: Strong Financials and Strategic Growth Drivers

TipRanksAug 7 06:49 ET

BrainsWay Analyst Ratings

BenzingaJun 5 06:28 ET

BrainsWay Analyst Ratings

BenzingaMay 9 07:21 ET

Buy Rating Affirmed for Brainsway Following Strong Financial Performance and Strategic Advancements

TipRanksMay 9 06:41 ET

BrainsWay Analyst Ratings

BenzingaMar 11 07:27 ET

Buy Rating and Raised Price Target for Brainsway Reflecting Strong Financial Growth and Expansion Potential

TipRanksMar 11 06:30 ET

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), Brainsway (BWAY) and Wave Life Sciences (WVE)

TipRanksMar 7 09:35 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP) and Brainsway (BWAY)

TipRanksNov 21, 2023 06:50 ET

BrainsWay Analyst Ratings

BenzingaNov 16, 2023 13:39 ET

Oppenheimer Adjusts Price Target on Brainsway to $6 From $5.50, Maintains Outperform Rating

MT NewswiresNov 16, 2023 11:34 ET